STUART M. ESSIG, PH.D. currently serves as managing director of Prettybrook Partners LLC, investing in medical technology companies.
He has been Integra LifeSciences Corporation's chairman of the Board of Directors since 2012, and a director since he joined Integra in 1997. He served as the company’s chief executive officer from 1997 to 2012, building Integra into a global surgical products leader. During Stuart’s 20-year tenure with the company, Integra has grown revenues from $15 million to over $1 billion.
Before joining Integra, Dr. Essig was managing director of the medical technology practice at Goldman, Sachs & Co. He had 10 years of broad healthcare experience at Goldman Sachs, serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients.
Dr. Essig has chaired audit, compensation and nominating and governance committees, served as lead director, and participated in CEO succession processes on the boards of numerous public companies, ranging in size from several hundred million dollars to almost $30 billion in levered market capitalization.
In addition to Integra, Dr. Essig currently serves on the Board of Directors of SeaSpine Holdings Corporation (NASDAQ:SPNE) and Owens & Minor, Inc. (NYSE:OMI). He is also the chairman of the Board of Directors of private-equity backed Breg, Inc. Dr. Essig is an executive-in-residence at Cardinal Partners and a venture partner at Wellington Partners Advisory AG, both venture capital firms. He also serves as a senior advisor to TowerBrook Capital Partners and Water Street Healthcare Partners. Dr. Essig is a founding investor member of Tigerlabs, a Princeton-based business accelerator. He serves on the Leadership Counsel of the Princeton University School of Engineering and Applied Sciences, and the NACD Compensation Committee Chair Advisory Counsel.
Dr. Essig previously served on the Board of Directors of St. Jude Medical Corporation (NYSE:SJM) from 1999 to 2017, prior to its sale to Abbott Corporation. From 2005 until 2008, he served on the Board of Directors of Zimmer Holdings, Inc. (NYSE:ZMH), and from 1998 to 2002, he served on the Board of Directors of Vital Signs, Inc. (NASDAQ:VITL). Dr. Essig also served on the executive committee, nominating and governance committee, and as treasurer of ADVAMED, the Advanced Medical Technology Association. He is also involved in several non-profit charitable organizations, including from time to time serving on their boards. Since 2012, Dr. Essig has served on the Board of Directors of Trenton-area non-profit organization, Isles, Inc., and since 2006, he has served as a volunteer and fundraiser for the Children’s Brain Tumor Foundation.
Dr. Essig received an A.B. degree, and graduated with magna cum laude and Phi Beta Kappa honors from the Woodrow Wilson School of Public and International Affairs at Princeton University. He completed his M.B.A. and Ph.D. degrees in financial economics from the University of Chicago Graduate School of Business.
What is Stuart Essig's net worth?
The estimated net worth of Stuart Essig is at least $10.64 million as of May 23rd, 2024. Mr. Essig owns 487,922 shares of Integra LifeSciences stock worth more than $10,636,700 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Essig may own. Additionally, Mr. Essig receives an annual salary of $152,500.00 as Director at Integra LifeSciences. Learn More about Stuart Essig's net worth.
How old is Stuart Essig?
Mr. Essig is currently 62 years old. There are 6 older executives and no younger executives at Integra LifeSciences. The oldest executive at Integra LifeSciences is Mr. Robert T. Davis Jr., Executive VP & President of Tissue Technologies, who is 65 years old. Learn More on Stuart Essig's age.
What is Stuart Essig's salary?
As the Director of Integra LifeSciences Holdings Co., Mr. Essig earns $152,500.00 per year. There are 6 executives that earn more than Mr. Essig. The highest earning executive at Integra LifeSciences is Mr. Jan De Witte, President, CEO & Director, who commands a salary of $888,670.00 per year. Learn More on Stuart Essig's salary.
How do I contact Stuart Essig?
Has Stuart Essig been buying or selling shares of Integra LifeSciences?
Stuart Essig has not been actively trading shares of Integra LifeSciences over the course of the past ninety days. Most recently, on Thursday, May 23rd, Stuart Essig bought 52,641 shares of Integra LifeSciences stock. The stock was acquired at an average cost of $28.49 per share, with a total value of $1,499,742.09. Following the completion of the transaction, the chairman now directly owns 487,922 shares of the company's stock, valued at $13,900,897.78. Learn More on Stuart Essig's trading history.
Who are Integra LifeSciences' active insiders?
Are insiders buying or selling shares of Integra LifeSciences?
In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 52,641 shares worth more than $1,499,742.09. In the last year, insiders at the life sciences company sold shares 1 times. They sold a total of 1,700 shares worth more than $41,072.00. The most recent insider tranaction occured on December, 2nd when EVP Michael J Mcbreen sold 1,700 shares worth more than $41,072.00. Insiders at Integra LifeSciences own 3.1% of the company.
Learn More about insider trades at Integra LifeSciences. Information on this page was last updated on 12/2/2024.
